| Product Code: ETC8205426 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Malta import shipments of viral vectors and vaccines in 2024 continue to be dominated by key European countries, with the UK, Germany, Italy, Netherlands, and Spain as top exporters. The high Herfindahl-Hirschman Index (HHI) reflects the concentrated market landscape. Despite a modest compound annual growth rate (CAGR) of 2.77% from 2020 to 2024, there was a significant decline in growth rate from 2023 to 2024 at -50.11%. This shift may indicate a changing dynamic in the market or temporary factors impacting import trends. Continued monitoring and analysis will be crucial for stakeholders in this sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Viral Vector and Vaccine Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Viral Vector and Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Viral Vector and Vaccine Market - Industry Life Cycle |
3.4 Malta Viral Vector and Vaccine Market - Porter's Five Forces |
3.5 Malta Viral Vector and Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Malta Viral Vector and Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Malta Viral Vector and Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development for viral vector and vaccine technology |
4.2.2 Growing prevalence of infectious diseases in Malta and globally |
4.2.3 Technological advancements in viral vector and vaccine production processes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of viral vectors and vaccines |
4.3.2 High costs associated with research, development, and production of viral vectors and vaccines |
5 Malta Viral Vector and Vaccine Market Trends |
6 Malta Viral Vector and Vaccine Market, By Types |
6.1 Malta Viral Vector and Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Malta Viral Vector and Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Malta Viral Vector and Vaccine Market Revenues & Volume, By Adenovirus, 2021- 2031F |
6.1.4 Malta Viral Vector and Vaccine Market Revenues & Volume, By Fowlpox Virus, 2021- 2031F |
6.1.5 Malta Viral Vector and Vaccine Market Revenues & Volume, By Attenuated Yellow Fever, 2021- 2031F |
6.1.6 Malta Viral Vector and Vaccine Market Revenues & Volume, By Vaccinia Virus Vectors, 2021- 2031F |
6.2 Malta Viral Vector and Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Malta Viral Vector and Vaccine Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.2.3 Malta Viral Vector and Vaccine Market Revenues & Volume, By Biopharmaceutical Companies, 2021- 2031F |
6.2.4 Malta Viral Vector and Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Malta Viral Vector and Vaccine Market Import-Export Trade Statistics |
7.1 Malta Viral Vector and Vaccine Market Export to Major Countries |
7.2 Malta Viral Vector and Vaccine Market Imports from Major Countries |
8 Malta Viral Vector and Vaccine Market Key Performance Indicators |
8.1 Research and development expenditure in viral vector and vaccine technology |
8.2 Number of clinical trials for viral vectors and vaccines conducted in Malta |
8.3 Adoption rate of viral vector and vaccine technology in healthcare facilities |
9 Malta Viral Vector and Vaccine Market - Opportunity Assessment |
9.1 Malta Viral Vector and Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Malta Viral Vector and Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Malta Viral Vector and Vaccine Market - Competitive Landscape |
10.1 Malta Viral Vector and Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Malta Viral Vector and Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here